Unraveling the Shared Genetics of Common Epilepsies and General Cognitive Ability

Overview

Journal medRxiv

Date 2024 Apr 8

PMID 38585944

Authors

Naz Karadag

Espen Hagen

Alexey A Shadrin

Dennis van der Meer

Kevin S OConnell

Zillur Rahman

Gleda Kutrolli

Nadine Parker

Shahram Bahrami

Vera Fominykh

Kjell Heuser

Erik Tauboll

Torill Ueland

Nils Eiel Steen

Srdjan Djurovic

Anders M Dale

Oleksandr Frei

Ole A Andreassen

Olav B Smeland

Affiliations

Soon will be listed here.

Abstract

Objective: Cognitive impairment is prevalent among individuals with epilepsy, and it is possible that genetic factors can underlie this relationship. Here, we investigated the potential shared genetic basis of common epilepsies and general cognitive ability (COG).

Methods: We applied linkage disequilibrium score (LDSC) regression, MiXeR and conjunctional false discovery rate (conjFDR) to analyze different aspects of genetic overlap between COG and epilepsies. We used the largest available genome-wide association study data on COG ( = 269,867) and common epilepsies ( = 27,559 cases, 42,436 controls), including the broad phenotypes 'all epilepsy', focal epilepsies and genetic generalized epilepsies (GGE), and as well as specific subtypes. We functionally annotated the identified loci using a variety of biological resources and validated the results in independent samples.

Results: Using MiXeR, COG (11.2k variants) was estimated to be almost four times more polygenic than 'all epilepsy', GGE, juvenile myoclonic epilepsy (JME), and childhood absence epilepsy (CAE) (2.5k - 2.9k variants). The other epilepsy phenotypes were insufficiently powered for analysis. We show extensive genetic overlap between COG and epilepsies with significant negative genetic correlations (-0.23 to -0.04). COG was estimated to share 2.9k variants with both GGE and 'all epilepsy', and 2.3k variants with both JME and CAE. Using conjFDR, we identified 66 distinct loci shared between COG and epilepsies, including novel associations for GGE (27), 'all epilepsy' (5), JME (5) and CAE (5). The implicated genes were significantly expressed in multiple brain regions. The results were validated in independent samples (COG: = 1.0 × 10; 'all epilepsy': = 5.6 × 10).

Significance: Our study demonstrates a substantial genetic basis shared between epilepsies and COG and identifies novel overlapping genomic loci. Enhancing our understanding of the relationship between epilepsies and COG may lead to the development of novel comorbidity-targeted epilepsy treatments.

References

Yu H, Shih Y, Su T, Lin K, Yiu C, Lin Y . Preoperative IQ predicts seizure outcomes after anterior temporal lobectomy. Seizure. 2009; 18(9):639-43. DOI: 10.1016/j.seizure.2009.07.009. View

Anttila V, Bulik-Sullivan B, Finucane H, Walters R, Bras J, Duncan L . Analysis of shared heritability in common disorders of the brain. Science. 2018; 360(6395). PMC: 6097237. DOI: 10.1126/science.aap8757. View

Smeland O, Bahrami S, Frei O, Shadrin A, OConnell K, Savage J . Genome-wide analysis reveals extensive genetic overlap between schizophrenia, bipolar disorder, and intelligence. Mol Psychiatry. 2019; 25(4):844-853. PMC: 6609490. DOI: 10.1038/s41380-018-0332-x. View

Cheng W, Frei O, van der Meer D, Wang Y, OConnell K, Chu Y . Genetic Association Between Schizophrenia and Cortical Brain Surface Area and Thickness. JAMA Psychiatry. 2021; 78(9):1020-1030. PMC: 8223140. DOI: 10.1001/jamapsychiatry.2021.1435. View

. Global, regional, and national burden of epilepsy, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019; 18(4):357-375. PMC: 6416168. DOI: 10.1016/S1474-4422(18)30454-X. View

Okbay A, Beauchamp J, Fontana M, Lee J, Pers T, Rietveld C . Genome-wide association study identifies 74 loci associated with educational attainment. Nature. 2016; 533(7604):539-42. PMC: 4883595. DOI: 10.1038/nature17671. View

. GWAS meta-analysis of over 29,000 people with epilepsy identifies 26 risk loci and subtype-specific genetic architecture. Nat Genet. 2023; 55(9):1471-1482. PMC: 10484785. DOI: 10.1038/s41588-023-01485-w. View

Jacoby A, Snape D, Baker G . Determinants of quality of life in people with epilepsy. Neurol Clin. 2009; 27(4):843-863. DOI: 10.1016/j.ncl.2009.06.003. View

Bahrami S, Shadrin A, Frei O, OConnell K, Bettella F, Krull F . Genetic loci shared between major depression and intelligence with mixed directions of effect. Nat Hum Behav. 2021; 5(6):795-801. PMC: 8217082. DOI: 10.1038/s41562-020-01031-2. View

10.

Kalilani L, Sun X, Pelgrims B, Noack-Rink M, Villanueva V . The epidemiology of drug-resistant epilepsy: A systematic review and meta-analysis. Epilepsia. 2018; 59(12):2179-2193. DOI: 10.1111/epi.14596. View

11.

Leu C, Richardson T, Kaufmann T, van der Meer D, Andreassen O, Westlye L . Pleiotropy of polygenic factors associated with focal and generalized epilepsy in the general population. PLoS One. 2020; 15(4):e0232292. PMC: 7188256. DOI: 10.1371/journal.pone.0232292. View

12.

Oliver K, Scheffer I, Bennett M, Grinton B, Bahlo M, Berkovic S . Genes4Epilepsy: An epilepsy gene resource. Epilepsia. 2023; 64(5):1368-1375. PMC: 10952165. DOI: 10.1111/epi.17547. View

13.

Schwartzman A, Lin X . The effect of correlation in false discovery rate estimation. Biometrika. 2012; 98(1):199-214. PMC: 3412603. DOI: 10.1093/biomet/asq075. View

14.

Kanner A, Helmstaedter C, Sadat-Hossieny Z, Meador K . Cognitive disorders in epilepsy I: Clinical experience, real-world evidence and recommendations. Seizure. 2020; 83:216-222. DOI: 10.1016/j.seizure.2020.10.009. View

15.

Strang K, Golde T, Giasson B . MAPT mutations, tauopathy, and mechanisms of neurodegeneration. Lab Invest. 2019; 99(7):912-928. PMC: 7289372. DOI: 10.1038/s41374-019-0197-x. View

16.

Hermann B, Struck A, Busch R, Reyes A, Kaestner E, McDonald C . Neurobehavioural comorbidities of epilepsy: towards a network-based precision taxonomy. Nat Rev Neurol. 2021; 17(12):731-746. PMC: 8900353. DOI: 10.1038/s41582-021-00555-z. View

17.

Smeland O, Frei O, Shadrin A, OConnell K, Fan C, Bahrami S . Discovery of shared genomic loci using the conditional false discovery rate approach. Hum Genet. 2019; 139(1):85-94. DOI: 10.1007/s00439-019-02060-2. View

18.

Holen B, Kutrolli G, Shadrin A, Icick R, Hindley G, Rodevand L . Genome-wide analyses reveal shared genetic architecture and novel risk loci between opioid use disorder and general cognitive ability. Drug Alcohol Depend. 2024; 256:111058. PMC: 11831617. DOI: 10.1016/j.drugalcdep.2023.111058. View

19.

Brooks-Kayal A, Bath K, Berg A, Galanopoulou A, Holmes G, Jensen F . Issues related to symptomatic and disease-modifying treatments affecting cognitive and neuropsychiatric comorbidities of epilepsy. Epilepsia. 2013; 54 Suppl 4:44-60. PMC: 3924317. DOI: 10.1111/epi.12298. View

20.

Bulik-Sullivan B, Loh P, Finucane H, Ripke S, Yang J, Patterson N . LD Score regression distinguishes confounding from polygenicity in genome-wide association studies. Nat Genet. 2015; 47(3):291-5. PMC: 4495769. DOI: 10.1038/ng.3211. View